Nanisx


Medical device company focused on developing and commercializing minimally invasive outpatient spine surgery technologies. The company develops patented implants and biologics, publishes clinical evidence, trains physicians in proprietary less-exposure surgical techniques, and maintains regulatory clearances for multiple device platforms.

Industries

cosmetic-surgery
medical-device

Nr. of Employees

medium (51-250)


Products

Interspinous fixation implant system

Posterior supplemental fixation system designed for the non-cervical spine to achieve supplemental fusion via plate attachment to spinous processes; intended for use with bone graft material.

Sacroiliac joint transfixation titanium implant system

Percutaneous lateral-oblique transfixation implant system designed to transfix the sacroiliac joint and achieve fusion while avoiding gluteal muscles and major vessels.

Transfacet pedicle screw fixation system

Minimally invasive transfacet pedicle screw fixation approach for percutaneous spine fusion intended for outpatient use.

Synthetic bioactive ceramic combined with demineralized bone matrix (osteobiologic)

A synthetic bioactive glass ceramic combined with DBM formulated as an osteobiologic for promoting bone regeneration in fusion procedures.


Services

Hands-on training courses and lab sessions to teach less-exposure surgical techniques and device implantation for surgeons and interventional physicians.

Onboarding and commercial support for distributors to sell and support spinal implants and biologics in target markets.

Expertise Areas

  • Outpatient spine surgery
  • Minimally invasive surgical techniques
  • Interspinous fixation and non-pedicle supplemental fixation
  • Sacroiliac joint transfixation techniques
  • Show More (6)

Key Technologies

  • Interspinous fixation implant systems
  • Transfacet pedicle screw fixation systems
  • Percutaneous fluoroscopy-guided lateral-oblique sacroiliac transfixation technique
  • Synthetic bioactive glass combined with demineralized bone matrix (osteobiologic)
  • Show More (4)

News & Updates

Five-year clinical outcomes study assessing an interspinous fixation system.

Publication comparing posterior oblique technique against lateral technique for sacroiliac joint fusion.

Multicenter case report describing a percutaneous lateral-oblique transfixation technique for revisions.

Reported metrics include over 19,000 devices implanted, 25+ global patents, 7+ US FDA cleared devices, $49M+ product revenues, 20+ research papers, and adoption in 10+ countries.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.